Sasaki M, Hosoya N, Saruhashi M
R&D Center, Terumo Corporation, Kanagawa, Japan. Masatomi_Sasakiterumo.co.jp.
Artif Organs. 2000 Oct;24(10):779-89. doi: 10.1046/j.1525-1594.2000.06489.x.
There has been a demand for hemodialysis membranes of better biocompatibility, the use of which would reduce the incidence of complications in patients who have been under long hemodialysis treatment. We developed a surface modification technique consisting of forming efficiently a synthetic polymer layer on the inside of the regenerated cellulose hollow fiber without impairing fiber performance. Our newly developed membrane has excellent biocompatibility by modifying the inner surface and by immobilizing vitamin E (alpha-tocopherol), which serves as an antioxidant, to the modified surface.
人们一直对具有更好生物相容性的血液透析膜有需求,使用这种膜将降低长期接受血液透析治疗的患者并发症的发生率。我们开发了一种表面改性技术,该技术包括在不损害纤维性能的情况下,在再生纤维素中空纤维内部高效形成一层合成聚合物层。我们新开发的膜通过对内表面进行改性以及将作为抗氧化剂的维生素E(α-生育酚)固定在改性表面上,具有出色的生物相容性。